Dividend
-
-
-
-
-
-
-
NeoGenomics Reports 51% Revenue Growth to Record $96 Million in the First Quarter
-
-
-
-
-
-
-
NeoGenomics Redeems 100% of Series A Redeemable Preferred Stock
-
-
-
-
-
-
-
NeoGenomics Reports 122% Revenue Growth to $60.5 Million and 11% Reduction in Average Cost per Test in the Fourth Quarter of 2016
-
-
-
-
-
454,583 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


